Interius BioTherapeutics
Biotechnology ResearchPennsylvania, United States11-50 Employees
Interius BioTherapeutics is a biotechnology research company based in Philadelphia, Pennsylvania. It develops cell-therapy approaches that aim to generate CAR T and CAR NK cells inside patients’ bodies, with the goal of delivering therapies that could be faster, potentially less expensive, and more widely accessible than current CAR T treatments. The organization is now part of Kite, a Gilead company focused on advancing cures with cell therapy. In recent years, Interius has pursued clinical development activities, including regulatory approval to expand a Phase 1 trial of INT2104 into Europe, and it has extended its European footprint. As a small to mid-sized company, it operates within the biotechnology research space and concentrates on in vivo strategies for CAR-based therapies.
1-888-653-2347 
support@leadiq.com 
